Patent Assignment
Reel/Frame 054341/0270
Assignment of Assignor's Interest
Recorded: 2020-11-11
Pages: 2
Assignor
IMMUNOCORE LLC
Executed: 2017-06-02
Assignee
IMMUNOCORE LIMITED
101 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
Covered Property
(1)
Dosing Regimen for GP100-Specific Tcr - Anti-CD3 Scfv Fusion Protein
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
Assignment of Assignor's Interest
Nov 10, 2020
From: COUGHLIN, CHRISTINA
To: IMMUNOCORE LLC
Reel/Frame 054324/0320 →
Patent Security Agreement
Nov 8, 2022
From: IMMUNOCORE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 061899/0866 →
Release of Security Interest
Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →
Release of Security Interest
Nov 11, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOCORE LIMITED
Reel/Frame 069197/0672 →